SCHEMBL3476340

SCHEMBL3476340

C=C[Si](C)(C)O[Si](CCCCOC(=O)C(=C)C)(O[Si](C)(C)C=C)O[Si](C)(C)C=C

nearest known ligand 0.49

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.49
THRB P10828 1/20 0.39
POLB P06746 1/20 0.39
APEX1 P27695 1/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL395316 0.95 TSHR (0.46) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5068000 0.89 TSHR (0.41) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5701671 0.89 TSHR (0.43) TSHRTHRBPOLBAPEX1HTT
SCHEMBL3478409 0.88 TSHR (0.49) TSHRTHRBPOLBAPEX1HTT
SCHEMBL3476983 0.88 TSHR (0.49) TSHRTHRBPOLBAPEX1HTT
SCHEMBL15483421 0.87 TSHR (0.39) TSHRTHRBPOLBAPEX1HTT
SCHEMBL5702056 0.86 TSHR (0.44) TSHRTHRBPOLBAPEX1HTT
SCHEMBL15483422 0.86 TSHR (0.38) TSHRTHRBPOLBAPEX1HTT
SCHEMBL397519 0.84 TSHR (0.54) TSHRTHRBPOLBAPEX1HTT
SCHEMBL3477369 0.84 TSHR (0.46) TSHRTHRBPOLBAPEX1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4135623-B1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER RXSIGHT INC (US) 2026-04-08 EP disclosed
US-20260069403-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE RXSIGHT, INC. (US) 2026-03-12 US disclosed
US-20240252311-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER RXSIGHT, INC. 2024-08-01 US disclosed
EP-4294325-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE RxSight, Inc. (US) 2023-12-27 EP disclosed
CN-116867464-A Composite optically tunable intraocular lens with diffractive structure RX视觉股份有限公司 2023-10-10 CN disclosed
EP-4135623-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER RxSight, Inc. (US) 2023-02-22 EP disclosed
CN-115397365-A Composite light adjustable intraocular lens with adhesion promoter RX视觉股份有限公司 2022-11-25 CN disclosed
WO-2022177821-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE RXSIGHT, INC. (US) 2022-08-25 WO disclosed
US-20210322152-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER RXSIGHT, INC. (US) 2021-10-21 US disclosed
WO-2021211888-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH ADHESION PROMOTER RXSIGHT, INC. (US) 2021-10-21 WO disclosed
US-20210251744-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE RXSIGHT, INC. (US) 2021-08-19 US disclosed
EP-2396355-B1 COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS VISIOGEN INC (US) 2018-05-23 EP disclosed
US-8680172-B2 Copolymers for intraocular lens systems VISIOGEN, INC. (US) 2014-03-25 US disclosed
US-20130245756-A1 COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS LILLY MING INTERNATIONAL, INC. 2013-09-19 US disclosed
US-8430928-B2 Copolymers for intraocular lens systems VISIOGEN, INC. (US) 2013-04-30 US disclosed
US-20120245684-A1 COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS VISIOGEN, INC. (US) 2012-09-27 US disclosed
US-8222360-B2 Copolymers for intraocular lens systems VISIOGEN, INC. (US) 2012-07-17 US disclosed
US-20100211170-A1 COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS VISIOGEN, INC. (US) 2010-08-19 US disclosed
WO-2010093823-A2 COPOLYMERS FOR INTRAOCULAR LENS SYSTEMS VISIOGEN, INC. (US) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260069403-A1 COMPOSITE LIGHT ADJUSTABLE INTRAOCULAR LENS WITH DIFFRACTIVE STRUCTURE IGLV6-57, SMCHD1, UACA TSHR 819/4885THRB 577/4885POLB 2928/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.